RXRX
Recursion Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +2.9% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | -2 | 264.97M | $972.27M | +5 | −6 |
| Q1 2026 | 107 | +3 | 243.54M | $747.81M | +9 | −7 |
| Q4 2025 | 104 | +2 | 261.79M | $1.07B | +4 | −1 |
| Q3 2025 | 16 | -2 | 173.92M | $848.75M | — | −3 |
| Q2 2025 | 16 | 0 | 153.65M | $777.46M | — | — |
| Q1 2025 | 13 | +3 | 87.35M | $462.12M | +3 | — |
| Q4 2024 | 10 | 0 | 84.02M | $567.97M | — | — |
| Q3 2024 | 9 | +2 | 69.10M | $455.38M | +2 | — |
| Q2 2024 | 7 | — | 63.72M | $477.87M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 32.35M | -1.3% | $218.66M | 1.8% | ▼ Trim | 3 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 24.86M | -1.5% | $168.08M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 24.86M | -1.5% | $168.08M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 24.86M | -1.5% | $168.08M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 24.86M | -1.5% | $168.08M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (pasivo) | 12.58M | — | $85.03M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 6.09M | +12.1% | $41.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasivo) | 6.09M | +12.1% | $41.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Norges Bank ✦ (pasivo) | 3.47M | -3.0% | $23.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 2.74M | +1069.5% | $18.52M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 1.66M | +4.0% | $11.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 131.99K | +17.4% | $893,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 114.94K | +9.4% | $777,029 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 114.94K | +9.4% | $777,029 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 114.94K | +9.4% | $777,029 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 114.94K | +9.4% | $777,029 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Millennium Management ✦ | 28.31K | -27.0% | $191,376 | 0.0% | ▼ Trim | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 333 tenedores, 334.81M acciones, $1.02B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.